TX-ROKA
ROKA Sports Inc., the Austin, TX based performance multisport company, has announced the release of its new Advanced Performance for Extreme Conditions (A.P.EX ) line of eyewear. The collection was designed from scratch for the athlete who requires maximum field of view, protection, ultra-lightweight, and seamless fit and retention. The Advanced Performance collection is incredibly versatile, coming in five styles and up to ten lens tint options, so athletes can completely customize their eyewear to meet their specific needs.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180313006426/en/
The unique design of ROKA’s Advanced Performance collection is the realization of more than two years of stealth R&D by ROKA’s eyewear division, an all-star team of designers and engineers based in Irvine, California, who were assembled specifically for this mission and were drawn from Apple, Oakley, Under Armour, and other leading brands. Upon formation, ROKA Co-Founders Rob Canales and Kurt Spenser challenged the team, which has over 110 years combined experience making performance eyewear, to design and build the best sport optics on the planet from the inside out, with a primary focus on function in extreme conditions.
“This is truly a breakthrough in performance eyewear,” says ROKA Co-Founder and CEO Rob Canales. “We build products for the most demanding athletes in the world, and through meticulous attention to detail and the aggregation of incremental gains, our team has delivered. While other brands are cutting performance and quality to satisfy their monopolist owners, we’ve gone all in with a truly independent line that is with uncompromising performance.”
The A.P.EX line consists of three different frame options, with multiple lens height configurations: The SL-1, SL-1x, SR-1, SR-1x, and TL-1. Weighing in at only 21 – 25 grams, every style features ultra-lightweight materials and construction without compromising durability. An adjustable titanium core offers a customized fit, and advanced materialization with ROKA’s patented GEKO™ technology on the nose pads and temples ensure a rock solid fit under the most adverse training and racing conditions.
All five styles feature premium nylon lens options by Carl Zeiss Vision that come standard with market-leading hydrophobic, oleophobic, anti-scratch, anti-fog, and anti-reflectance coatings. Whether riding in the glaring sun or running through rain and snow, athletes will have multiple contrast and mirror options for the specific demands of the day.
“The moment I slipped on the ROKA sunglasses, I knew they had set a new standard in the performance eyewear market,” says eight-time triathlon world champion Javier Gómez. “There is nothing else that comes close in terms of weight, security, and optics. ROKA’s technical apparel and goggles have been a secret weapon for me in multiple world championships. I’m thrilled to have that same world-beating standard for my eyewear.”
Gómez is one of more than 40 elite athletes to debut the Advanced Performance eyewear in 2018. Regardless of the arena or challenge, ROKA eyewear is designed for athletes seeking to redefine standards, to break barriers, and to find every advantage possible. Within a few weeks of their release, Carlos Sainz drove them to victory at the Dakar Rally in South America, and Esmee Visser took them to the top of the Olympic podium in speed skating in PyeongChang.
“I first tried ROKA sunglasses in January—about a month before the Olympics,” Visser says. “The sunglasses I used previously were good, but I always had problems with my eyes tearing up. With ROKA’s SR-1 sunglasses, I had better protection and fewer tears, and they weighed less, so it was an easy decision to use them at the Olympics.”
Advanced Performance optics have also helped pro cyclists Bryan Coquard and Magnus Cort Nielsen reach the top of the World Tour podium in 2018, out-sprinting the best cyclists in the world. They will also be the eyewear of choice for Dan Martin this July when he attempts to become the second Irishman ever to win the Tour de France.
“I pride myself on being innovative and finding every little advantage that I can,” says Martin. “When I looked into the ROKA brand, I knew they fit with my philosophy.” Martin says. “From the moment I put on the Advanced Performance eyewear, I knew ROKA had designed something truly better. The weight and fit is unlike anything else I’ve ever tried.”
Remaining true to its DNA as the top endurance sports brand in the world and its roots as the leading high-performance triathlon brand, a large number of triathletes including Ironman Linsey Corbin, the fastest American woman at the Iron distance, have chosen ROKA as their eyewear partner for the hardest single-day endurance event in the world, joining Gómez and original ROKA athlete Jesse Thomas.
The mission to create the most advanced high-performance eyewear on the planet began with the challenge presented by ROKA’s first sponsored athlete, Jesse Thomas, who wanted to blend his classic style of retro aviators with the lightweight fit and protection of high-performance optics.
“We’re passionate about designing the most advanced high performance products on the market for athletes who seek to redefine the standard. We are a dedicated team of creators, designers, engineers, and athletes who share that mission. We are incredibly proud of the results thus far. Stay tuned.” says ROKA Co-Founder and Chief Creative Officer, Kurt Spenser. “This incredible group of athletes all share a commitment to perform at the highest level in their respective arenas, and to go beyond what was previously thought possible. We work tirelessly to honor that commitment by delivering the most advanced eyewear in the world.”
Each of the five styles in the Advanced Performance collection has been optimized for specific use cases to accommodate a range of fit and function preferences. With its rimless design, the SL-1 and SL-1x provide athletes a completely unobstructed field of view and venting, even while in the extreme forward aero position under the hottest conditions. The SR-1 and SR-1x are designed for security, confidence, and speed for the absolutely fastest training and racing days, and they’re equally as comfortable underneath a helmet as they are out on the run. The sleek and stylish TL-1 is a high-performing, twin-lens sport frame that offers versatility, security, and ultralight performance, and is sure to be an instant favorite across a variety of applications.
All five styles feature ROKA’s patented GEKO™ pads on the nose and temples for optimal traction and comfort, as well as titanium core wires in the temples to provide a customized fit for every athlete. The SL-1, SL-1x, SR-1 and SR-1x feature nine interchangeable accessory lens options, so athletes can quickly change the tint to take on the specific conditions of any ride, run or race. The polarized lens options in the TL-1 are cut for superior optics and exceed all industry standards for polarization efficiency. ROKA’s proprietary polarization process minimizes distortion and warpage better than any other eyewear on the market.
“When we debuted our first line of eyewear in 2016, we sought to be the first brand to blend classic optical style with high performance and comfort,” said James Oman, Vice President of Engineering. “With the Advanced Performance line, we are pushing beyond limits to create a new standard of optics, protection and versatility. It’s a bold new category of eyewear that will forever change what athletes expect from a pair of sunglasses.”
About ROKA
ROKA started in a garage in Austin, Texas with humble beginnings and laser-beam focus. Our mission is to unlock human potential. To equip, empower, inspire and ignite. We serve those who seek to redefine the standard, to push themselves to the limit – whatever and wherever that may be. When we see an opportunity to innovate, to challenge the status quo, to disrupt a complacent or monopolistic market, we go all in.
Since our launch in 2013, our athletes have won over a dozen world titles and have been instrumental in the design and development of our patented and award-winning products. In 2016, we were proud to send 18 athletes to the Rio Olympics, and even prouder to take home Gold and Bronze. This year in PyeongChang, we continued the tradition, with ROKA athletes taking home Olympic Gold and Bronze in our most cutting edge products.
With our debut eyewear collection in late 2016, we have set a new bar by making ultralight performance eyewear with zero compromise on style, and with a patented design for sunglasses that stay put on your face even during the most extreme training and racing. Featuring a suite of the world's most advanced materials and patented technologies, our award-winning Ultralight Performance Eyewear delivers on our promise to create the finest technical equipment on the planet, full stop. For more information, visit www.roka.com/pages/contact-us .
View source version on businesswire.com: http://www.businesswire.com/news/home/20180313006426/en/
Contact:
ROKA
Diane Thibert
VP Communications & Public Relations
(310)
804-2400
diane@roka.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom